{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/105869842"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "For the past six years, Dr. Royal has worked at Cadence Pharmaceuticals, Inc. most recently as VP, Clinical Development and Medical Affairs, where he was responsible for activities such as the design, oversight, and completion of the OFIRMEV?? (acetaminophen) injection clinical development program and new drug application, and medical support for pre-launch and launch activities, which resulted in" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "bio-medicine.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/106056832"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/105869842"] } } }
